UK markets close in 7 minutes

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
149.37-0.87 (-0.58%)
As of 11:20AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts21212222
Avg. Estimate-1.11-1.06-3.6-1.87
Low estimate-1.57-1.69-5.56-4.38
High estimate-0.36-0.31-1.072.31
Year ago EPS-2.211.15-3.52-3.6
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts22212626
Avg. Estimate442.73M459.44M1.87B2.3B
Low estimate415M441M1.73B1.48B
High estimate485M495.5M2B2.97B
Year ago sales318.75M750.53M1.83B1.87B
Sales growth (year/est)38.90%-38.80%2.30%22.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.37-1.34-1.32-1.18
Actual EPS-2.211.15-1.1-0.52
Difference-0.842.490.220.66
Surprise %-61.30%185.80%16.70%55.90%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.11-1.06-3.6-1.87
7 days ago-1.11-1.06-3.6-1.87
30 days ago-1.04-1.1-4.11-1.76
60 days ago-1.04-1.1-4.18-1.76
90 days ago-1.04-1.1-4.15-1.63
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days10112310
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesALNYIndustrySector(s)S&P 500
Current qtr.49.80%N/AN/AN/A
Next qtr.-192.20%N/AN/AN/A
Current year-2.30%N/AN/AN/A
Next year48.10%N/AN/AN/A
Next 5 years (per annum)-177.50%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A